Document 0489
 DOCN  M9650489
 TI    Decisions to get HIV tested and to accept antiretroviral therapies among
       gay/bisexual men: implications for secondary prevention efforts.
 DT    9605
 AU    Stall R; Hoff C; Coates TJ; Paul J; Phillips KA; Ekstrand M; Kegeles S;
       Catania J; Daigle D; Diaz R; Center for AIDS Prevention Studies,
       University of California, San; Francisco 94143, USA.
 SO    J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Feb 1;11(2):151-60.
       Unique Identifier : AIDSLINE MED/96147315
 AB    The objective of this study was to report prevalence rates of adherence
       by HIV-seropositive individuals to medical recommendations for the
       treatment of HIV infection, a behavioral pattern referred to as AIDS
       secondary prevention. We report cross-sectional data (n = 2,593) from
       two household-based and two bar-based samples of gay/bisexual men,
       gathered in 1992 in Tucson, Arizona, and Portland, Oregon. The main
       outcome variables were prevalence of HIV antibody testing and adherence
       to recommended secondary prevention behaviors to prevent onset of AIDS
       symptoms. Approximately one-third of the gay/bisexual men in these
       samples do not know their current HIV status. Of the gay/bisexual men
       who do know that they are HIV-seropositive, approximately three-fourths
       adhere to each of the secondary prevention recommendations, as
       appropriate to their stage of disease progression. In a multivariate
       logistic model, three variables distinguished between HIV-seropositive
       men who did and did not adhere: perceived antiviral treatment norms (OR
       = 1.4, CI = 1.1-1.7), perceived efficacy of secondary prevention
       treatments (OR = 1.4, CI = 1.1-1.7), and quality of the relationship
       with one's health-care provider (OR = 2.5, CI = 1.6-4.0). These findings
       indicate that efforts to support AIDS secondary prevention behaviors can
       occur not only through health education to change the perceptions of
       at-risk communities about the options available to delay the onset of
       opportunistic infections among HIV-seropositive individuals but also by
       enhancing effective doctor/patient communication.
 DE    Acquired Immunodeficiency Syndrome/ETIOLOGY/*PREVENTION & CONTROL
       Adolescence  Adult  Aged  Aged, 80 and over  Antiviral
       Agents/*THERAPEUTIC USE  Arizona  AIDS Serodiagnosis/*PSYCHOLOGY
       *Bisexuality/PSYCHOLOGY  Comparative Study  Cross-Sectional Studies
       *Homosexuality, Male/PSYCHOLOGY  Human  HIV
       Seropositivity/COMPLICATIONS/DRUG THERAPY/*PSYCHOLOGY  Male  Middle Age
       Oregon  Patient Acceptance of Health Care/*PSYCHOLOGY  Patient
       Compliance/PSYCHOLOGY  Support, U.S. Gov't, P.H.S.  JOURNAL ARTICLE
       MULTICENTER STUDY

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).